CellDrop for elite equine athletics

CellDrop is commercializing a first of its kind encapsulated, allogenic stem cell therapy for faster and more durable healing of tendon and ligament injuries in elite equine athletes.

Implementation in the veterinary market will provide crucial evidence and early revenue generation to speed its translation to humans, where it can treat numerous debilitating orthopedic conditions like Osteoarthritis.

Roadmap

Now
Rodent Study
Preliminary evidence demonstrating enhanced healing efficacy in Sprague Dawley rat achilles injury model.
Horse Study
Equine study demonstrating enhanced efficacy in equine suspensory ligament defects.
Equipment Installation & Scale Up
Scaled production of our encapsulated stem cell biotherapeutic.
Go To Market
Sales targeting thoroughbred racehorse veterinarians
Meet Our Team
our team